Press-release for stocks for snynf

symbols : Snynf

save search

Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| Email alert Add to watchlist
study

Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
RLYB | News | $1.79 1.7% 1.68% 270K

| 0.57% | O: 1.14% H: 3.37% C: -0.56%
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 0.82% | O: 0.41% H: 1.19% C: 0.41%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 0.85% | O: 0.85% H: 0.0% C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K

Health Technology

| 2.57% | O: 0.08% H: 4.54% C: 2.49%
NKTR | News | $1.37 10.48% 9.49% 2M

Health Technology

| 9.68% | O: 5.65% H: 7.63% C: 3.82%
MOR | News | $17.97 -0.06% -0.06% 330K

Health Technology

| -0.06% | O: -0.06% H: 0.0% C: 0.0%
GLPG | News | $29.09 0.03% -0.14% 80K

Health Technology

| -0.03% | O: -0.41% H: 1.52% C: 0.38%
AMRN | News | $0.8648 0.64% 0.64% 740K

Health Technology

| -1.17% | O: -2.31% H: 2.33% C: 1.16%
GOOGL | News S | $156.3 1.43% 1.41% 26M

Technology Services

| 1.42% | O: 0.14% H: 2.16% C: 1.28%
GOOG | News S | $157.96 1.44% 1.42% 15M

Technology Services

| 1.43% | O: 0.19% H: 2.04% C: 1.24%
OCX | News | $2.51 0.4% 0.4% 63K

Health Technology

| 0.4% | O: 0.8% H: 1.59% C: -0.4%
VXRT | News | $0.7625 0.91% 0.9% 940K

Health Technology

| 0.0% | O: 2.63% H: 2.56% C: -2.56%
TXMD | News | $1.88 1.08% 1.06% 19K

Health Technology

| 1.08% | O: 0.54% H: 3.21% C: 0.53%
biopharma

Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff
Published: 2024-04-22 (Crawled : 16:00) - biospace.com/
AMRN | News | $0.8648 0.64% 0.64% 740K

Health Technology

| -1.17% | O: -2.31% H: 2.33% C: 1.16%
GOOGL | News S | $156.3 1.43% 1.41% 26M

Technology Services

| 1.42% | O: 0.14% H: 2.16% C: 1.28%
GOOG | News S | $157.96 1.44% 1.42% 15M

Technology Services

| 1.43% | O: 0.19% H: 2.04% C: 1.24%
OCX | News | $2.51 0.4% 0.4% 63K

Health Technology

| 0.4% | O: 0.8% H: 1.59% C: -0.4%
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 0.82% | O: 0.41% H: 1.19% C: 0.41%
VXRT | News | $0.7625 0.91% 0.9% 940K

Health Technology

| 0.0% | O: 2.63% H: 2.56% C: -2.56%
TXMD | News | $1.88 1.08% 1.06% 19K

Health Technology

| 1.08% | O: 0.54% H: 3.21% C: 0.53%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 0.85% | O: 0.85% H: 0.0% C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K

Health Technology

| 2.57% | O: 0.08% H: 4.54% C: 2.49%
NKTR | News | $1.37 10.48% 9.49% 2M

Health Technology

| 9.68% | O: 5.65% H: 7.63% C: 3.82%
MOR | News | $17.97 -0.06% -0.06% 330K

Health Technology

| -0.06% | O: -0.06% H: 0.0% C: 0.0%
GLPG | News | $29.09 0.03% -0.14% 80K

Health Technology

| -0.03% | O: -0.41% H: 1.52% C: 0.38%
RLYB | News | $1.79 1.7% 1.68% 270K

| 0.57% | O: 1.14% H: 3.37% C: -0.56%
biopharma

Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-22 (Crawled : 22:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| Email alert Add to watchlist
REGN | News | $899.71 0.32% 0.32% 340K

Health Technology

| Email alert Add to watchlist
genetic cell research therapy

Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| Email alert Add to watchlist
AZN | News | $70.12 2.29% 2.24% 4.8M

Health Technology

| Email alert Add to watchlist
AZNCF | News | $136.2 -4.19% 1.7K

Health Technology

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510

Health Technology

| Email alert Add to watchlist
ABT | News | $107.07 -0.2% 0.0% 4.9M

Health Technology

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| Email alert Add to watchlist
GSK | News | $40.59 2.11% -0.36% 3.8M

Health Technology

| Email alert Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M

Health Technology

| Email alert Add to watchlist
RBGPF | News | $51.75 6.46% 3.6K

Consumer Non-Durables

| Email alert Add to watchlist
RBGLY | News | $10.35 -2.05% 500K

Manufacturing

| Email alert Add to watchlist
drug astrazeneca set key therapeutics market

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 0.85% | O: 0.85% H: 0.0% C: 0.0%
pharma cancer for

AbbVie Tops Doctor Ranking of Immunology Companies, Handily Beating Pfizer and J&J
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 0.82% | O: 0.41% H: 1.19% C: 0.41%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 0.85% | O: 0.85% H: 0.0% C: 0.0%
abbvie immunology

Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.36 0.91% -0.52% 1.6M

Health Technology

| 1.6% | O: 0.42% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 1.68% | O: 0.82% H: 0.0% C: 0.0%
MIRM | $24.17 1.51% 1.49% 250K

Health Technology

| 2.55% | O: -0.68% H: 2.52% C: 1.71%
report million reach treatment market

Sanofi Cuts Jobs in U.S. Vaccines Division as Part of Restructuring
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 1.68% | O: 0.82% H: 0.0% C: 0.0%
sanofi

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 2.88% | O: 0.83% H: 1.35% C: 1.2%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 1.68% | O: 0.82% H: 0.0% C: 0.0%
miss

J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectati...
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 2.88% | O: 0.83% H: 1.35% C: 1.2%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 1.68% | O: 0.82% H: 0.0% C: 0.0%
miss

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M

Health Technology

| 0.07% | O: -0.4% H: 3.01% C: 2.94%
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 2.88% | O: 0.83% H: 1.35% C: 1.2%
ABT | News | $107.07 -0.2% 0.0% 4.9M

Health Technology

| 0.63% | O: -0.75% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 1.68% | O: 0.82% H: 0.0% C: 0.0%
first treatment for

Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
Published: 2024-04-19 (Crawled : 16:00) - biospace.com/
RLYB | News | $1.79 1.7% 1.68% 270K

| 3.51% | O: -3.51% H: 10.3% C: 6.67%
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 2.88% | O: 0.83% H: 1.35% C: 1.2%
VXRT | News | $0.7625 0.91% 0.9% 940K

Health Technology

| -12.64% | O: -5.75% H: 4.88% C: -7.32%
TXMD | News | $1.88 1.08% 1.06% 19K

Health Technology

| -0.53% | O: -0.53% H: 5.32% C: -1.06%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 1.68% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K

Health Technology

| 3.22% | O: -4.57% H: 6.41% C: 5.46%
NKTR | News | $1.37 10.48% 9.49% 2M

Health Technology

| 0.74% | O: -1.48% H: 0.0% C: -6.77%
MOR | News | $17.97 -0.06% -0.06% 330K

Health Technology

| -0.44% | O: -0.17% H: 0.11% C: -0.22%
GLPG | News | $29.09 0.03% -0.14% 80K

Health Technology

| -0.51% | O: -1.23% H: 0.94% C: 0.76%
AMRN | News | $0.8648 0.64% 0.64% 740K

Health Technology

| -6.35% | O: -5.24% H: 0.0% C: 0.0%
GOOGL | News S | $156.3 1.43% 1.41% 26M

Technology Services

| 0.62% | O: 0.57% H: 0.1% C: -1.35%
GOOG | News S | $157.96 1.44% 1.42% 15M

Technology Services

| 0.66% | O: 0.54% H: 0.15% C: -1.29%
OCX | News | $2.51 0.4% 0.4% 63K

Health Technology

| -3.09% | O: -1.93% H: 0.39% C: -1.57%
biopharma

Quebec's INESSS recommends BEYFORTUS for the prevention of RSV for all infants 8 months of age and younger(1)
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.0% | O: 0.0% H: 0.0% C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| -0.16% | O: -1.81% H: 0.0% C: 0.0%
beyfortus for rsv

World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"
Published: 2024-04-17 (Crawled : 04:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 0.88% | O: 1.05% H: 0.0% C: 0.0%
BMRN | $89.52 1.0% 0.99% 1.2M

Health Technology

| -1.5% | O: 0.26% H: 0.0% C: 0.0%
day bleeding world for

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
Published: 2024-04-17 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 0.88% | O: 1.05% H: 0.0% C: 0.0%
sclerosis for potential

Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
JNJ | News | $149.12 0.82% 0.0% 9.3M

Health Technology

| 2.8% | O: -0.04% H: 0.28% C: -0.16%
SNY | News | $47.125 1.78% 1.75% 2.1M

Health Technology

| 0.88% | O: 1.05% H: 0.0% C: 0.0%
treatment global growth market

IGM Biosciences Announces Refocusing of Sanofi Collaboration
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology